APA (7th ed.) Citation

MM, G., SH, J., E, H., E, R., S, D., PS, K., & AR, S. (2022). Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease. International journal of molecular sciences, 23(23), . https://doi.org/10.3390/ijms232314938

Chicago Style (17th ed.) Citation

MM, Gayed, Jung SH, Huggins E, Rodriguez-Rassi E, DeArmey S, Kishnani PS, and Stiles AR. "Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease." International Journal of Molecular Sciences 23, no. 23 (2022). https://doi.org/10.3390/ijms232314938.

MLA (9th ed.) Citation

MM, Gayed, et al. "Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease." International Journal of Molecular Sciences, vol. 23, no. 23, 2022, https://doi.org/10.3390/ijms232314938.